Home-Based Device Beneficial for Obese Patients With Knee OA

This article originally appeared here.
Share this content:
Home-Based Device Beneficial for Obese Patients With Knee OA
Home-Based Device Beneficial for Obese Patients With Knee OA

THURSDAY, July 30, 2015 (HealthDay News) -- For obese individuals, a novel, biomechanical, home-based gait-training device is associated with improvements in gait parameters at three and 12 months, according to a study published online July 28 in the International Journal of Rheumatic Diseases.

Omri Lubovsky, M.D., from Barzilay Medical Center in Ashkelon, Israel, and colleagues examined the effect of a gait-training device on gait patterns in a retrospective analysis. Data were included from 105 obese subjects (32 males, 73 females) with knee osteoarthritis who completed a 12-month program.

The researchers observed significant improvement in each of the gait parameters at three months, and further improvement at 12 months (P = 0.03 overall). At three and 12 months, gait velocity increased by 11.8 and 16.1 percent, respectively, while single-limb support of the more symptomatic knee increased by 2.5 and 3.6 percent, respectively. Pain, stiffness, and functional limitations were reduced at three months (each P < 0.001); these improved further at 12 months. Pain decreased by 34.7 and 45.7 percent, respectively, while functional limitation decreased by 35.0 and 44.7 percent, respectively. Significant improvements were seen in the Physical and Mental Scales of the Short Form-36 (P < 0.001) at three months, with greater improvements seen at 12 months.

"The study participants reported relief in pain and showed significant improvement in gait pattern after following the combined device and exercise program for 12 months," the authors write.

Several authors disclosed financial ties to AposTherapy.

Abstract
Full Text (subscription or payment may be required)

Share this content:

is free, fast, and customized just for you!




Already a member?

Sign In Now »

Trending Activities

All Professions

Drug Lookup

Browse drugs by: BrandGenericDisease

More in Home

FDA Permits Marketing of Brain Stimulation Device for OCD

FDA Permits Marketing of Brain Stimulation Device for ...

FDA previously approved transcranial magnetic stimulation for major depression, certain migraines

Comments Open on End of NIH Review for Gene Therapy Studies

Comments Open on End of NIH Review for ...

NIH oversight panel no longer plans to review all applications for gene therapy experiments

U.S. Measles Outbreak Hits 107 Cases in 21 States, D.C.

U.S. Measles Outbreak Hits 107 Cases in 21 ...

Outbreak on track to exceed last year's; most of the people who got measles weren't vaccinated

is free, fast, and customized just for you!




Already a member?

Sign In Now »